{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:13:27Z","timestamp":1784906007848,"version":"3.55.0"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>As the global population ages, immunosenescence is emerging as a critical determinant of cancer outcomes in older adults. Although programmed cell death protein 1\/protein programmed death-ligand 1 (PD-1\/PD-L1) blockade has significantly improved the treatment of multiple malignancies, its efficacy in older patients is highly heterogeneous, and the biological basis for this variability remains incompletely understood. Current evidence indicates that immunosenescence reshapes antitumour immunity through thymic involution, reduced T cell receptor diversity, chronic low-grade inflammation, and expansion of immunosuppressive cell populations, thereby impairing antigen presentation, weakening T cell activation and effector function, promoting terminal T cell exhaustion, and reinforcing suppressive tumour microenvironments. Together, these changes form an important mechanistic basis for the limited benefit of PD-1\/PD-L1 blockade in older patients. Meanwhile, potentially targetable processes, including metabolic dysregulation, mitochondrial dysfunction, defective autophagy\u2013mitophagy, redox imbalance, and gut microbiota dysbiosis, are increasingly recognized as modifiable contributors to age-associated resistance to immunotherapy. In this Review, we discuss how immunosenescence remodels antitumour immunity and constrains responses to PD-1\/PD-L1 blockade in older patients, and we summarize potential strategies to improve immunotherapeutic efficacy in this population. These insights may inform future mechanistic studies, biomarker discovery, and the development of age-adapted therapeutic strategies.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1781004","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:34:16Z","timestamp":1784612056000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunosenescence shapes the tumor immune microenvironment and limits PD-1\/PD-L1 blockade efficacy in older patients with cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaoyu","family":"Niu","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Henan Provincial People's Hospital","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwaregul","family":"Nur","sequence":"additional","affiliation":[{"name":"Henan Health Commission Key Laboratory of Cancer Radiation Injury and Protection, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkang","family":"Xie","sequence":"additional","affiliation":[{"name":"The First Clinical School of Medicine, Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[{"name":"The First Clinical School of Medicine, Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longhao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Henan Provincial People\u2019s Hospital","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]},{"name":"Internet Medical and System Applications of National Engineering Laboratory, the First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"RD","year":"2011","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/4.4.195","article-title":"THE IMMUNOLOGIC THEORY OF AGING","volume":"4","author":"RL","year":"1964","journal-title":"The Gerontologist"},{"key":"B3","doi-asserted-by":"publisher","first-page":"eRB4733","DOI":"10.31744\/einstein_journal\/2019RB4733","article-title":"Immunosenescence: participation of T lymphocytes and myeloid-derived suppressor cells in aging-related immune response changes","volume":"17","author":"AS","year":"2019","journal-title":"Einstein"},{"key":"B4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41232-018-0082-9","article-title":"The impact of senescence-associated T cells on immunosenescence and age-related disorders","volume":"38","author":"Fukushima","year":"2018","journal-title":"Inflamm Regen"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2010.12.014","article-title":"Immune defence against EBV and EBV-associated disease","volume":"23","author":"HM","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00867-9","article-title":"Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1","volume":"23","author":"Chamoto","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.05.026","article-title":"Correction of age-associated defects in dendritic cells enables CD4(+) T cells to eradicate tumors","volume":"187","author":"Zhivaki","year":"2024","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12979-022-00302-y","article-title":"Composition of the infiltrating immune cells in the brain of healthy individuals: effect of aging","volume":"19","author":"Nevalainen","year":"2022","journal-title":"Immun Ageing"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.18632\/aging.205637","article-title":"HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma","volume":"16","author":"Liu","year":"2024","journal-title":"Aging"},{"key":"B10","doi-asserted-by":"publisher","first-page":"115145","DOI":"10.1016\/j.ejca.2024.115145","article-title":"Cancer immunotherapy in elderly patients: The concept of immune senescence challenged by clinical experience","volume":"214","author":"Mathilde","year":"2024","journal-title":"Eur J Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"005020","DOI":"10.1136\/jitc-2022-005020","article-title":"Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy","volume":"10","author":"Xia","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1116","article-title":"Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations","volume":"24","author":"Kugel","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"100577","DOI":"10.1016\/j.esmoop.2022.100577","article-title":"The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regression","volume":"7","author":"Kim","year":"2022","journal-title":"ESMO Open"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.538174","article-title":"Efficacy of Anti-PD-1\/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis","volume":"11","author":"Nie","year":"2021","journal-title":"Front Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.07.004","article-title":"Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1-positive advanced non-small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies","volume":"135","author":"Nosaki","year":"2019","journal-title":"Lung Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"103081","DOI":"10.1016\/j.eclinm.2025.103081","article-title":"Efficacy and safety of immune checkpoint inhibitors in elderly patients with advanced non-small cell lung cancer: a systematic review and meta-analysis","volume":"81","author":"Yao","year":"2025","journal-title":"EClinicalMedicine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12307-014-0158-2","article-title":"Pivotal role of pervasive neoplastic and stromal cells reprogramming in circulating tumor cells dissemination and metastatic colonization","volume":"7","author":"Meseure","year":"2014","journal-title":"Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s12307-012-0124-9","article-title":"The immune microenvironment of human tumors: general significance and clinical impact","volume":"6","author":"Fridman","year":"2013","journal-title":"Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-031210-101324","article-title":"Natural innate and adaptive immunity to cancer","volume":"29","author":"Vesely","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.07.008","article-title":"The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures","volume":"39","author":"Galon","year":"2013","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2013.03.004","article-title":"From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer","volume":"25","author":"Angell","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.11.009","article-title":"Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy","volume":"470","author":"Lei","year":"2020","journal-title":"Cancer Lett"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-9597-4_1","article-title":"Introduction to the Immune System","volume":"2024","author":"McComb","year":"2019","journal-title":"Methods Mol Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The Tumor Microenvironment Innately Modulates Cancer Progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-4141","article-title":"Cancer-Associated Fibroblasts Suppress CD8+ T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade","volume":"82","author":"Jenkins","year":"2022","journal-title":"Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1720948115","article-title":"Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment","volume":"115","author":"Peranzoni","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B27","doi-asserted-by":"publisher","first-page":"0287","DOI":"10.3390\/biology12020287","article-title":"CAR Based Immunotherapy of Solid Tumours-A Clinically Based Review of Target Antigens","volume":"12","author":"Maher","year":"2023","journal-title":"Biology (Basel)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1714478115","article-title":"Thymic involution and rising disease incidence with age","volume":"115","author":"Palmer","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.16","article-title":"Immunometabolism: Unravelling the puzzle to longevity and immunity","volume":"16","author":"E","year":"2016","journal-title":"Nature Reviews. Immunology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/path.2104","article-title":"Immunosenescence of ageing","volume":"211","author":"AL","year":"2007","journal-title":"The Journal of Pathology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.18.1.529","article-title":"The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection","volume":"18","author":"BF","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"DI","year":"2009","journal-title":"Nature Reviews. Immunology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13045-018-0578-4","article-title":"Lessons learned from the blockade of immune checkpoints in cancer immunotherapy","volume":"11","author":"X","year":"2018","journal-title":"J Hematol Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12524","article-title":"New checkpoints in cancer immunotherapy","volume":"276","author":"L","year":"2017","journal-title":"Immunol Rev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"EJ","year":"2011","journal-title":"Nat Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101165","article-title":"Functional exhaustion of CD4+ T lymphocytes during primary cytomegalovirus infection","volume":"189","author":"P","year":"2012","journal-title":"Journal of Immunology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf2807","article-title":"Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade","volume":"354","author":"Pauken","year":"2016","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350711","article-title":"Immune senescence","author":"ME","year":"1994","journal-title":"Ann Neurol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3109\/10409238.2016.1172554","article-title":"The Immunoproteasome in oxidative stress, aging, and disease","volume":"51","author":"HK","year":"2016","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2014.05.007","article-title":"Cellular signaling in the aging immune system","volume":"29","author":"T","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"100998","DOI":"10.1016\/j.arr.2019.100998","article-title":"Activation of immunosuppressive network in the aging process","volume":"57","author":"A","year":"2020","journal-title":"Ageing Res Rev"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: Markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0912461","article-title":"Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer","volume":"93","author":"Verschoor","year":"2013","journal-title":"J Leukoc Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.11.005","article-title":"Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer","volume":"42","author":"Launonen","year":"2024","journal-title":"Cancer Cell"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0609385","article-title":"Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation","volume":"86","author":"G","year":"2009","journal-title":"J Leukoc Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"A","year":"2008","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12062","article-title":"Targeting macrophages rescues age-related immune deficiencies in C57BL\/6J geriatric mice","volume":"12","author":"Jackaman","year":"2013","journal-title":"Aging Cell"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00526","article-title":"Macrophage Depletion in Elderly Mice Improves Response to Tumor Immunotherapy, Increases Anti-tumor T Cell Activity and Reduces Treatment-Induced Cachexia","volume":"9","author":"Duong","year":"2018","journal-title":"Front Genet"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.01.001","article-title":"Type 2 cytokine signaling in macrophages protects from cellular senescence and organismal aging","volume":"57","author":"Zhou","year":"2024","journal-title":"Immunity"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-1300","article-title":"Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer","volume":"14","author":"Matusiak","year":"2024","journal-title":"Cancer Discov"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.676236","article-title":"Age-Related Changes in Thymic Central Tolerance","volume":"12","author":"Srinivasan","year":"2021","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1159\/000355303","article-title":"Regulatory T cells and the immune aging process: a mini-review","volume":"60","author":"Jagger","year":"2014","journal-title":"Gerontology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2006.01.008","article-title":"Are regulatory T-cells linked with aging","volume":"41","author":"C","year":"2006","journal-title":"Exp Gerontol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001505","article-title":"A major role for Bim in regulatory T cell homeostasis","volume":"186","author":"Chougnet","year":"2011","journal-title":"J Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01385","article-title":"Aged Gut Microbiota Contributes to Systemical Inflammaging after Transfer to Germ-Free Mice","volume":"8","author":"Fransen","year":"2017","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1172\/JCI136466","article-title":"DCAF1 regulates Treg senescence via the ROS axis during immunological aging","volume":"130","author":"Guo","year":"2020","journal-title":"J Clin Invest"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.06.014","article-title":"Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunity","volume":"42","author":"You","year":"2024","journal-title":"Cancer Cell"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"LM","year":"2009","journal-title":"The Journal of Experimental Medicine"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.05.013","article-title":"Interruption of the intratumor CD8(+) T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy","volume":"42","author":"Geels","year":"2024","journal-title":"Cancer Cell"},{"key":"B61","doi-asserted-by":"publisher","first-page":"12491","DOI":"10.1038\/s41598-022-16776-1","article-title":"Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells","volume":"12","author":"Martins","year":"2022","journal-title":"Sci Rep"},{"key":"B62","doi-asserted-by":"publisher","first-page":"eadi7764","DOI":"10.1126\/sciadv.adi7764","article-title":"Syndecan-1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy","volume":"10","author":"Liu","year":"2024","journal-title":"Sci Adv"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e2205378119","DOI":"10.1073\/pnas.2205378119","article-title":"Aging-associated and CD4 T-cell-dependent ectopic CXCL13 activation predisposes to anti-PD-1 therapy-induced adverse events","volume":"119","author":"Tsukamoto","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.01.013","article-title":"Impact of aging on immune-related adverse events generated by anti-programmed death (ligand)PD-(L)1 therapies","volume":"129","author":"C","year":"2020","journal-title":"European Journal of Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.4161\/cc.9.16.13120","article-title":"Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-program","volume":"9","author":"MV","year":"2010","journal-title":"Cell Cycle"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.18632\/aging.100296","article-title":"Roles of the Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging","volume":"3","author":"LS","year":"2011","journal-title":"Aging"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2014.10.006","article-title":"Stem cells and aberrant signaling of molecular systems in skin aging","volume":"19","author":"Y","year":"2015","journal-title":"Ageing Res Rev"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.05.001","article-title":"Resveratrol for cancer therapy: Challenges and future perspectives","volume":"515","author":"Ren","year":"2021","journal-title":"Cancer Lett"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.4161\/cc.8.12.8809","article-title":"Pharmacologic inhibition of MEK and PI-3K converges on the mTOR\/S6 pathway to decelerate cellular senescence","volume":"8","author":"ZN","year":"2009","journal-title":"Cell Cycle"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4765","article-title":"PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers","volume":"69","author":"S","year":"2009","journal-title":"Cancer Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4161\/cc.8.12.8810","article-title":"At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence","volume":"8","author":"ZN","year":"2009","journal-title":"Cell Cycle"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0015-0","article-title":"The functions and regulation of the PTEN tumour suppressor: new modes and prospects","volume":"19","author":"YR","year":"2018","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0283","article-title":"Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy","volume":"6","author":"W","year":"2016","journal-title":"Cancer Discov"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/nature12437","article-title":"Synthetic lethal metabolic targeting of cellular senescence in cancer therapy","volume":"501","author":"D\u00f6rr","year":"2013","journal-title":"Nature"},{"key":"B75","doi-asserted-by":"publisher","first-page":"9932218","DOI":"10.1155\/2021\/9932218","article-title":"Effects and Mechanisms of Resveratrol on Aging and Age-Related Diseases","volume":"2021","author":"Zhou","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1126\/science.1205407","article-title":"Spatial coupling of mTOR and autophagy augments secretory phenotypes","volume":"332","author":"Narita","year":"2011","journal-title":"Science"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2015.10.009","article-title":"Measuring In Vivo Mitophagy","volume":"60","author":"Sun","year":"2015","journal-title":"Mol Cell"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/nature16187","article-title":"Autophagy maintains stemness by preventing senescence","volume":"529","author":"Garc\u00eda-Prat","year":"2016","journal-title":"Nature"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.00171-22","article-title":"Upregulation of PD-L1 in Senescence and Aging","volume":"42","author":"Onorati","year":"2022","journal-title":"Mol Cell Biol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102646","article-title":"Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity","volume":"12","author":"Verdura","year":"2020","journal-title":"Aging"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.937476","article-title":"Vitamin D metabolism pathway polymorphisms are associated with efficacy and safety in patients under anti-PD-1 inhibitor therapy","volume":"13","author":"Luo","year":"2022","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"112553","DOI":"10.1016\/j.biopha.2021.112553","article-title":"The potential role of vitamin C in empowering cancer immunotherapy","volume":"146","author":"Bedhiafi","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgab096","article-title":"Involvement of PD-L1-mediated tumor-intrinsic signaling and immune suppression in tumorigenic effect of \u03b1-tocopherol","volume":"43","author":"Sun","year":"2022","journal-title":"Carcinogenesis"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05388-4","article-title":"Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes","volume":"611","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12943-024-02096-7","article-title":"Cellular senescence and SASP in tumor progression and therapeutic opportunities","volume":"23","author":"Dong","year":"2024","journal-title":"Mol Cancer"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1126\/science.1240527","article-title":"Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment","volume":"342","author":"N","year":"2013","journal-title":"Science"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.12938\/bmfh.33.99","article-title":"Establishment of intestinal bacteriology","volume":"33","author":"T","year":"2014","journal-title":"Bioscience of Microbiota, Food and Health"},{"key":"B88","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1471-2180-9-123","article-title":"The Firmicutes\/Bacteroidetes ratio of the human microbiota changes with age","volume":"9","author":"D","year":"2009","journal-title":"BMC Microbiol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2024.03.002","article-title":"A specific enterotype derived from gut microbiome of older individuals enables favorable responses to immune checkpoint blockade therapy","volume":"32","author":"Zhu","year":"2024","journal-title":"Cell Host Microbe"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-024-00678-0","article-title":"Gut microbial features and circulating metabolomic signatures of frailty in older adults","volume":"4","author":"Pu","year":"2024","journal-title":"Nat Aging"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Science"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"V","year":"2018","journal-title":"Science"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients","volume":"359","author":"V","year":"2018","journal-title":"Science"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-024-01068-4","article-title":"The interplay between diet and the gut microbiome: implications for health and disease","volume":"22","author":"Ross","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e184321","DOI":"10.1172\/JCI184321","article-title":"The gut microbiome and cancer response to immune checkpoint inhibitors","volume":"135","author":"Gazzaniga","year":"2025","journal-title":"The Journal of Clinical Investigation"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1781004\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:50:03Z","timestamp":1784904603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1781004\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":96,"alternative-id":["10.3389\/fimmu.2026.1781004"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1781004","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"article-number":"1781004"}}